Libya vs Sint Maarten (Dutch part): Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Libya
0.2%
in 2024
Sint Maarten (Dutch part)
0.2%
in 2024
Libya rank
78th
Sint Maarten (Dutch part) rank
78th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Libya
- Sint Maarten (Dutch part)
How they compare
Libya currently reports 0.2% against 0.2% in Sint Maarten (Dutch part), a difference of 0.0%.
Across all 10 years both countries report, Sint Maarten (Dutch part) has been ahead every year.
Libya ranks 78th and Sint Maarten (Dutch part) ranks 78th of 215 countries.
Sint Maarten (Dutch part) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Libya | Sint Maarten (Dutch part) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.3% | 0.1% | Sint Maarten (Dutch part) |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Libya or Sint Maarten (Dutch part)?
- Libya, at 0.2% against 0.2% in Sint Maarten (Dutch part) as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Libya and Sint Maarten (Dutch part)?
- 0.0%, with Libya ahead.
- How many years of comparable data are there for Libya and Sint Maarten (Dutch part)?
- 10 years are reported by both, from 2015 to 2024.
- How do Libya and Sint Maarten (Dutch part) rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Libya ranks 78th and Sint Maarten (Dutch part) ranks 78th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.